These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32008800)

  • 1. [Thrombosis and platelet dysfunction in myeloproliferative neoplasms].
    Mornet C; Galinat H; Mingant F; Ianotto JC; Lippert E
    Rev Med Interne; 2020 May; 41(5):319-324. PubMed ID: 32008800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of bleeding and thrombosis in myeloproliferative disorders.
    Landolfi R; Marchioli R; Patrono C
    Thromb Haemost; 1997 Jul; 78(1):617-21. PubMed ID: 9198226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of thrombosis in JAK2V617F myeloproliferative neoplasms].
    Guy A; James C
    Med Sci (Paris); 2019; 35(8-9):651-658. PubMed ID: 31532377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of thrombotic and hemorrhagic complications in myeloproliferative and myelodysplastic syndromes].
    Vlădăreanu AM; Popov V; Bumbea H; Ciufu C; Vasilache V; Petre A; Onisâi M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):14-9. PubMed ID: 21688554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
    Wehmeier A; Daum I; Jamin H; Schneider W
    Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Wehmeier A; Südhoff T; Meierkord F
    Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms.
    Stein BL; Martin K
    Blood; 2019 Nov; 134(22):1902-1911. PubMed ID: 31778549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
    Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease.
    Wehmeier A; Scharf RE; Fricke S; Schneider W
    Haemostasis; 1989; 19(5):251-9. PubMed ID: 2777137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time.
    Baker RI; Manoharan A
    Eur J Haematol; 1988 Mar; 40(3):267-72. PubMed ID: 3356243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytosis and Thrombosis: Is There Really a Correlation?
    Galvez C; Stein BL
    Curr Hematol Malig Rep; 2020 Aug; 15(4):261-267. PubMed ID: 32399765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms.
    Rungjirajittranon T; Owattanapanich W; Ungprasert P; Siritanaratkul N; Ruchutrakool T
    BMC Cancer; 2019 Feb; 19(1):184. PubMed ID: 30819138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
    Chang H; Shih LY; Michelson AD; Dunn P; Frelinger AL; Wang PN; Kuo MC; Lin TL; Wu JH; Tang TC
    Acta Haematol; 2013; 130(3):181-7. PubMed ID: 23751441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients.
    Grossi A; Rosseti S; Vannucchi AM; Rafanelli D; Ferrini PR
    Clin Lab Haematol; 1988; 10(2):167-75. PubMed ID: 3416575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets and thrombosis in myeloproliferative diseases.
    Harrison CN
    Hematology Am Soc Hematol Educ Program; 2005; ():409-15. PubMed ID: 16304412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis in myeloproliferative neoplasms.
    Falanga A; Marchetti M
    Semin Thromb Hemost; 2014 Apr; 40(3):348-58. PubMed ID: 24610470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders.
    Repsold L; Joubert AM
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Baş B; Köksal A; Ozatli D; Haznedaroğlu I; Koşar A; Büyükaşik Y; Ozcebe O; Dündar S
    Clin Appl Thromb Hemost; 1999 Oct; 5(4):282-4. PubMed ID: 10726027
    [No Abstract]   [Full Text] [Related]  

  • 19. How to manage thrombosis in myeloproliferative neoplasms.
    Barbui T
    Curr Opin Oncol; 2011 Nov; 23(6):654-8. PubMed ID: 21986846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are MPNs vascular diseases?
    Finazzi G; De Stefano V; Barbui T
    Curr Hematol Malig Rep; 2013 Dec; 8(4):307-16. PubMed ID: 24037420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.